Research progress of antibody coupling technique in targeted drug delivery

Abstract Antibody‐drug conjugates are a cutting‐edge biotechnology recently attracting wide attention in the medical field. Binding antibodies to drug molecules could deliver drugs precisely to the site of the lesion, which shows great potential in the treatment of tumors and immune diseases. In this paper, we outlined the current popular antibody‐coupling techniques and summarized various common antibody‐coupling techniques, including antibody‐coupled small toxic molecules, antibody‐coupled oligenucleotides, antibody‐coupled cells, and antibody‐coupled polymers. It provided a new therapeutic strategy and means for targeted drug delivery technology. Finally, we discussed the challenges and future development of the antibody‐drug conjugates.

Authors

Institutions

Publication Details

Journal
Interdisciplinary medicine
Published
2025-04-14
DOI
https://doi.org/10.1002/inmd.20240108
Citations
1
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
article
Field-Weighted Citation Impact
1.36

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Research progress of antibody coupling technique in targeted drug delivery

Shi Hu, Dan Tan, Changhai Lei, Tiantian Wang et al.
1 citations
Interdisciplinary medicine
Monoclonal and Polyclonal Antibodies Research
1.36
article

Research progress of antibody coupling technique in targeted drug delivery

Shi Hu, Dan Tan, Changhai Lei, Tiantian Wang, Yuqing Wang, Mengqi Wang, Meng Li
article en
1 citations

Abstract

Abstract Antibody‐drug conjugates are a cutting‐edge biotechnology recently attracting wide attention in the medical field. Binding antibodies to drug molecules could deliver drugs precisely to the site of the lesion, which shows great potential in the treatment of tumors and immune diseases. In this paper, we outlined the current popular antibody‐coupling techniques and summarized various common antibody‐coupling techniques, including antibody‐coupled small toxic molecules, antibody‐coupled oligenucleotides, antibody‐coupled cells, and antibody‐coupled polymers. It provided a new therapeutic strategy and means for targeted drug delivery technology. Finally, we discussed the challenges and future development of the antibody‐drug conjugates.

Interdisciplinary medicineVol. 3(3)
Kyushu University (JP), Second Military Medical University (CN), Changhai Hospital (CN)
National Natural Science Foundation of China, Shanghai Rising-Star Program
Openalex Percentile: Top 21%
Monoclonal and Polyclonal Antibodies Research
1.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.